1st Quarter - Report

MUSCULAR DYSTROPHY ASSOCIATION, INC. for MUSCULAR DYSTROPHY ASSOCIATION, INC.

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Achieving a Better Life Experience (ABLE) Act of 2011 (H.R. 3423/S. 1872)

LobbyistCovered position, as disclosed
ANNIE KENNEDY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3423 (112th), S. 1872 (112th)

Health Issues HCR

Health care issues affecting individuals with neuromuscular disease, including transitional health care issues; S. 606, the Creating Hope Act; the Rare Disease Congressional Caucus; drug approval process and reauthorization of the Prescription Drug User Fee Amendments and Best Pharmaceuticals for Children and the Pediatric Research Equity Acts, including S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments Act, H.R. 4132, Faster Access to Specialized Treatments Act.

LobbyistCovered position, as disclosed
ANNIE KENNEDY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2113 (112th), S. 606 (112th), H.R. 4132 (112th)

Budget/Appropriations BUD

Department of Defense funding for research for Amyotrophic Lateral Sclerosis, contained in appropriations for Fiscal Year 2013

LobbyistCovered position, as disclosed
DAVID MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.